Medicare Enrolled
Dr. David Kraman, MD
Urology Physician · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kraman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kraman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kraman
Dr. David Kraman is an urology physician in Philadelphia, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Kraman performed 3,073 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kraman received a total of $6,901 from 46 pharmaceutical and/or device companies across 243 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kraman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 21% volume in PA
$6,901 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,073
Medicare services
Top 21% in PA for urology physician
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,045 | $2 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
693 | $65 | $190 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
272 | $8 | $60 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
224 | $36 | $130 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
214 | $99 | $275 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 144 | $136 | $755 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
114 | $192 | $700 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
91 | $65 | $130 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
47 | $107 | $245 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
42 | $67 | $175 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
37 | $62 | $275 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
37 | $41 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $123 | $350 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
25 | $41 | $275 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
24 | $28 | $115 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
13 | $126 | $2,578 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
13 | $98 | $190 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
12 | $20 | $180 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.4% high complexity
10.0% medium
89.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,901
Total received (2018-2024)
Avg $986/year across 7 years
Top 21% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
243
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,393
2023
$950
2022
$645
2021
$773
2020
$470
2019
$802
2018
$868
Payments by company (2024)
UROGEN PHARMA, INC.
$1,250
Sumitomo Pharma America, Inc.
$353
DENTSPLY IH AB
$340
Astellas Pharma US Inc
$183
ABBVIE INC.
$122
Ferring Pharmaceuticals Inc.
$40
180 Medical, Inc.
$29
Teleflex LLC
$23
Telix Pharmaceuticals
$22
IMMUNITYBIO, INC.
$16
C. R. Bard, Inc. & Subsidiaries
$15
Top 3 companies account for 81.2% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,747
UROGEN PHARMA, INC.
$1,250
DENTSPLY IH AB
$711
Sumitomo Pharma America, Inc.
$507
Janssen Biotech, Inc.
$373
PFIZER INC.
$274
NeoTract Inc.
$178
Medtronic, Inc.
$145
Ferring Pharmaceuticals Inc.
$138
ABBVIE INC.
$122
Myovant Sciences Inc.
$113
AbbVie, Inc.
$105
Avadel Specialty Pharmaceuticals, LLC
$102
AbbVie Inc.
$99
180 Medical, Inc.
$97
Bayer Healthcare Pharmaceuticals Inc.
$82
DENTSPLY IH Inc.
$66
Telix Pharmaceuticals
$66
Antares Pharma, Inc.
$62
Blue Earth Diagnostics Limited
$59
Myriad Genetic Laboratories, Inc.
$52
Coloplast Corp
$49
Bayer HealthCare Pharmaceuticals Inc.
$41
Clarus Therapeutics Inc.
$38
TOLMAR Pharmaceuticals, Inc.
$33
Dendreon Pharmaceuticals LLC
$30
MEDIVATION FIELD SOLUTIONS LLC
$30
Acerus Pharmaceuticals Corporation
$26
Daiichi Sankyo Inc.
$24
Teleflex LLC
$23
ConvaTec Inc.
$21
COLOPLAST CORP
$20
Merck Sharp & Dohme LLC
$19
Cure Medical LLC
$18
Tolmar, Inc.
$18
Boston Scientific Corporation
$18
UroGen Pharma, Inc.
$18
GENZYME CORPORATION
$17
Alnylam Pharmaceuticals Inc.
$17
Hollister Incorporated
$16
IMMUNITYBIO, INC.
$16
C. R. Bard, Inc. & Subsidiaries
$15
Endo Pharmaceuticals Inc.
$13
Prometheus Laboratories Inc.
$12
Photocure Inc
$11
Aytu BioScience, Inc
$11
Top 3 companies account for 53.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · Androgel · Axumin · BOTOX · Bard Urinary Drainage Bag · CONCERTOTM · Cure Catheter · Cysview · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL - ERECTILE DYSFUNCTION · GENTLECATH · ILLUCCIX · INJECTAFER · INTERSTIM · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LOFRIC · LUPRON DEPOT · LoFric · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OXLUMO · Otrexup · PROVENGE · Prolaris · Proleukin · ReTrace · SPEEDICATH · SUTENT · SpeediCath · TOVIAZ · UROLIFT · UroLift · VaPro Plus Pocket · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
321
County median income
$60,698
Nearest hospital to ZIP centroid (approximate)
NAZARETH HOSPITAL
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kraman is a clinical cardiology specialist, with above-average Medicare volume (top 21% in PA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kraman experienced with automated urinalysis?
Based on Medicare claims data, Dr. Kraman performed 1,045 automated urinalysis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kraman receive payments from pharmaceutical companies?
Yes. Dr. Kraman received a total of $6,901 from 46 companies across 243 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kraman's costs compare to other urology physicians in Philadelphia?
Dr. Kraman's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kraman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Philadelphia
Browse urology physicians in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
UROGEN PHARMA, INC. Payments to Doctors
See all physicians who received payments from UROGEN PHARMA, INC.
By company
DENTSPLY IH AB Payments to Doctors
See all physicians who received payments from DENTSPLY IH AB.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology